Stability of creatinine and cystatin C in whole blood

Clinical Biochemistry

Volumn 46, Issue 15, 2013, Pages 1611-1614

  Spithoven, E M ^a   Bakker, S J L ^a   Kootstra Ros, J E ^a   de Jong, P E ^a   Gansevoort, R T ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Creatinine; Cystatin C; Enzymatic assay; Stability; Whole blood

Indexed keywords

CREATININE; CYSTATIN C;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYMATIC ASSAY; ENZYME STABILITY; HUMAN; PRIORITY JOURNAL;

CREATININE; CYSTATIN C; ENZYMATIC ASSAY; STABILITY; WHOLE BLOOD;

BIOLOGICAL MARKERS; BLOOD PRESERVATION; CREATININE; CYSTATIN C; ENZYME ASSAYS; GLOMERULAR FILTRATION RATE; HUMANS; LIMIT OF DETECTION; MODELS, STATISTICAL; PROTEIN STABILITY; RENAL INSUFFICIENCY, CHRONIC; REPRODUCIBILITY OF RESULTS; SPECIMEN HANDLING;

EID: 84884354799     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2013.06.022     Document Type: Article

References (14)

1. Clark S., Youngman L.D., Palmer A., Parish S., Peto R., Collins R. Stability of plasma analytes after delayed separation of whole blood: implications for epidemiological studies. Int J Epidemiol 2003, 32(1):125-130.
2. Ford L., Berg J. Delay in separating blood samples affects creatinine measurement using the roche kinetic jaffe method. Ann Clin Biochem 2008, 45(Pt 1):83-87.
3. Boyanton B.L., Blick K.E. Stability studies of twenty-four analytes in human plasma and serum. Clin Chem 2002, 48(12):2242-2247.
4. Simpson W.G. Plasma creatinine and the effect of delay in separation of samples. Ann Clin Biochem 1992, 29(Pt 3):307-309. (Pt 3).
5. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 2013, (Suppl. 3):40.
6. Shepherd J., Warner M.H., Kilpatrick E.S. Stability of creatinine with delayed separation of whole blood and implications for eGFR. Ann Clin Biochem 2007, 44(Pt 4):384-387.
7. Tanner M., Kent N., Smith B., Fletcher S., Lewer M. Stability of common biochemical analytes in serum gel tubes subjected to various storage temperatures and times pre-centrifugation. Ann Clin Biochem 2008, 45(Pt 4):375-379.
8. Oddoze C., Lombard E., Portugal H. Stability study of 81 analytes in human whole blood, in serum and in plasma. Clin Biochem 2012, 45(6):464-469.
9. Newman D.J., Thakkar H., Edwards R.G., Wilkie M., White T., Grubb A.O., et al. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int 1995, 47(1):312-318.
10. Grubb A., Blirup-Jensen S., Lindstrom V., Schmidt C., Althaus H., Zegers I., et al. First certified reference material for cystatin C in human serum ERM-DA471/IFCC. Clin Chem Lab Med 2010, 48(11):1619-1621.
11. Inker L.A., Schmid C.H., Tighiouart H., Eckfeldt J.H., Feldman H.I., Greene T., et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 2012, 367(1):20-29.
12. Padala S., Tighiouart H., Inker L.A., Contreras G., Beck G.J., Lewis J., et al. Accuracy of a GFR estimating equation over time in people with a wide range of kidney function. Am J Kidney Dis 2012, 60(2):217-224.
13. World Health Organization Diagnostic imaging and laboratory technology. Use of anticoagulants in diagnostic laboratory investigations 2002.
14. Erlandsen E.J., Randers E., Kristensen J.H. Evaluation of the dade behring N latex cystatin C assay on the dade behring nephelometer II system. Scand J Clin Lab Invest 1999, 59(1):1-8.